(Q44760828)

6 December 2017

title

Therapeutic efficacy of once-daily oral administration of a Kunitz-type protease inhibitor, bikunin, in a mouse model and in human cancer (English)

1 reference

6 December 2017

1

Hiroshi Kobayashi

1 reference

6 December 2017

Tatsuo Yagyu

2

1 reference

6 December 2017

Kiyokazu Inagaki

3

1 reference

6 December 2017

Toshiharu Kondo

4

1 reference

6 December 2017

Mika Suzuki

5

1 reference

6 December 2017

Naohiro Kanayama

6

1 reference

6 December 2017

Toshihiko Terao

7

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 February 2004

1 reference

6 December 2017

1 reference

6 December 2017

volume

100

1 reference

6 December 2017

issue

4

1 reference

6 December 2017

page(s)

869-877

1 reference

Structure and function analysis of urinary trypsin inhibitor (UTI): identification of binding domains and signaling property of UTI by analysis of truncated proteins

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20034

Anti-metastatic therapy by urinary trypsin inhibitor in combination with an anti-cancer agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20034

Suppression of urokinase-type plasminogen activator expression from human ovarian cancer cells by urinary trypsin inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20034

Role of weekly paclitaxel in the treatment of advanced ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20034

7 January 2021

https://api.crossref.org/works/10.1002%2FCNCR.20034

1 reference

7 January 2021

Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20034

7 January 2021

The protease inhibitor bikunin, a novel anti-metastatic agent

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20034

7 January 2021

Suppression of invasion and peritoneal carcinomatosis of ovarian cancer cell line by overexpression of bikunin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20034

7 January 2021

Suppression of urokinase receptor expression by bikunin is associated with inhibition of upstream targets of extracellular signal-regulated kinase-dependent cascade

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20034

7 January 2021

Transforming Growth Factor-β1 Produced by Ovarian Cancer Cell Line HRA Stimulates Attachment and Invasion through an Up-regulation of Plasminogen Activator Inhibitor Type-1 in Human Peritoneal Mesothelial Cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20034

7 January 2021

A Kunitz-type protease inhibitor, bikunin, inhibits ovarian cancer cell invasion by blocking the calcium-dependent transforming growth factor-beta 1 signaling cascade

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20034

7 January 2021

Reduced bikunin gene expression as a factor of poor prognosis in ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20034

7 January 2021

Bikunin target genes in ovarian cancer cells identified by microarray analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20034

7 January 2021

Adenovirus-mediated gene transfer of urokinase plasminogen inhibitor inhibits angiogenesis in experimental arthritis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20034

7 January 2021

Identifiers

DOI

10.1002/CNCR.20034

1 reference

6 December 2017

1 reference